GSK3B and Parkinson disease: What is more, previous study reported that bilateral models of PD as MPTP-treated (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) monkeys, increased activation of GSK-3β was associated with L-dopa-induced dyskinesias7.